VILNIAUS MEDICINOS TECHNIKA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 199,477 | 186,946 | 283,564 | 270,119 | 294,480 | 297,580 | 325,610 | 296,944 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 16,468 | 39,492 | 54,998 | 53,470 | 9,913 | 35,859 | 49,998 | 41,886 |
| Equity | 320,000 | 359,492 | 414,490 | 467,960 | 477,873 | 513,732 | 563,730 | 605,616 |
| Liabilities | 35,639 | 13,801 | 25,145 | 25,675 | 10,759 | 14,354 | 29,900 | 7,962 |
| Non-current assets | 218,473 | 206,749 | 182,572 | 171,437 | 260,804 | 274,705 | 254,114 | 256,605 |
| Current assets | 137,166 | 166,544 | 257,063 | 322,198 | 227,828 | 253,381 | 339,408 | 356,865 |
| Total assets | 355,639 | 373,293 | 439,635 | 493,635 | 488,632 | 528,086 | 593,522 | 613,470 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 21,279 | 50,918 | 61,176 |
| Social insurance contributions | - | - | - | - | - | 13,392 | 13,467 | 14,073 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +4.7% | -6.3% | +51.7% | -4.7% | +9.0% | +1.1% | +9.4% | -8.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 4.6% | 10.6% | 12.5% | 10.8% | 2.0% | 6.8% | 8.4% | 6.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 5.1% | 11.0% | 13.3% | 11.4% | 2.1% | 7.0% | 8.9% | 6.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.3% | 21.1% | 19.4% | 19.8% | 3.4% | 12.1% | 15.4% | 14.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 20,115 | 21,571 | 36,986 | 38,588 | 42,069 | 44,637 | 51,412 | 46,886 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
VILNIAUS MEDICINOS TECHNIKA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-03-15 | 2026-03-15 | 2.19 |
| 2026-02-18 | 2026-03-11 | 2.19 |
| 2026-01-16 | 2026-02-16 | 2.19 |
| 2026-01-01 | 2026-01-14 | 2.19 |
| 2025-12-16 | 2025-12-30 | 2.19 |
| 2025-11-18 | 2025-12-14 | 2.19 |
| 2025-10-16 | 2025-11-16 | 2.18 |
| 2025-09-16 | 2025-10-14 | 2.17 |
| 2025-09-07 | 2025-09-14 | 2.17 |
| 2025-08-31 | 2025-09-03 | 2.17 |
| 2025-08-19 | 2025-08-29 | 2.17 |
| 2025-07-24 | 2025-08-17 | 2.17 |
| 2025-06-08 | 2025-06-09 | 166.16 |
| 2025-05-16 | 2025-06-04 | 166.16 |
| 2025-05-04 | 2025-05-14 | 118.94 |
| 2025-05-01 | 2025-05-01 | 118.94 |
| 2025-04-30 | 2025-04-30 | 118.64 |
| 2025-04-24 | 2025-04-29 | 118.94 |
| 2025-04-16 | 2025-04-23 | 118.64 |
| 2025-03-18 | 2025-04-14 | 19.48 |
| 2025-02-18 | 2025-03-16 | 19.48 |
VILNIAUS MEDICINOS TECHNIKA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-11-28 | 2025-12-15 | 0.37 |
| 2025-09-28 | 2025-11-25 | 0.37 |
| 2025-09-19 | 2025-09-25 | 0.37 |
| 2025-08-31 | 2025-09-14 | 0.37 |
| 2025-08-28 | 2025-08-30 | 0.41 |
| 2025-06-22 | 2025-08-25 | 0.41 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
VILNIAUS MEDICINOS TECHNIKA, UAB is a Private Limited Liability Company (code 122027976) engaged in the retail sale of other medical and orthopaedic goods. In the latest financial year 2025, the company generated revenue of €296.9K and net profit of €41.9K, corresponding to a profit margin of 14.1%. Revenue decreased by 8.8% year on year, while the two-year change was broadly stable at -0.2%, indicating that sales in 2025 remained close to the 2023 level after a stronger 2024. Profitability was lower than in 2024, when net profit reached €50.0K, but it remained above the €35.9K reported in 2023. The balance sheet strengthened further: equity increased to €605.6K, total assets reached €613.5K, and liabilities were only €8.0K. This resulted in an equity ratio of 98.7% and a debt-to-equity ratio of 0.01, showing very low leverage. Asset turnover stood at 0.48x, while ROE was 6.9% and ROA 6.8%. Revenue per employee was €49.5K and profit per employee €7.0K.